Skip to main content
Weiter zur Homepage der Europäischen Kommission (öffnet in neuem Fenster)
Deutsch de
CORDIS - Forschungsergebnisse der EU
CORDIS

Vaccinologists for Europe: Training network for developing next generation vaccines against mucosal pathogens

Ziel

"AntimicrobiaAntimicrobial resistance (AMR) and emerging viral pathogens pose significant global health threats, with mucosal infections contributing to severe morbidity and mortality. Current systemic immunization strategies fail to induce effective mucosal immunity, including tissue-resident memory cells (TRMs) and secretory IgA (sIgA). Addressing this gap requires targeted research and training in mucosal vaccinology. The Vax4eU network aims to advance next-generation mucosal vaccines through a multidisciplinary program for 16 Doctoral Candidates (DCs), focusing on vaccine candidates and technologies that induce robust mucosal immunity, prevent infection, and combat AMR.
Vax4eU integrates cutting-edge approaches, including AI-assisted antigen design, novel adjuvants, and tailored nanoparticle delivery systems. Research spans the vaccine pipeline, from drug substance design to preclinical evaluation. Work Package (WP) 1 focuses on antigens and adjuvants, using platforms like mRNA and fusion proteins, along with mucosal-targeting strategies such as ""Blood2Gut"" adjuvants. WP 2 develops advanced delivery systems, including polysaccharide, protein, and lipid nanoparticles and innovative mucosal adjuvants like cyclic dimeric AMP. WP 3 identifies CoIs and CoPs using high-dimensional tools and preclinical models, including pigs, which closely mimic human mucosal immunity.
The program combines research with robust training, offering DCs individualized projects, network-wide training in AI tools, regulatory processes, drug delivery, and preclinical studies. Collaboration with academic and non-academic partners ensures DCs gain insights into scientific and translational aspects of vaccinology, supported by secondments, expert mentoring, and interinstitutional collaboration.
By advancing mucosal vaccine technology and addressing AMR, Vax4eU aligns with European public health priorities, fostering a new generation of skilled vaccinologists to tackle global infectious diseases."

Wissenschaftliches Gebiet (EuroSciVoc)

Dieses Projekt wurde noch nicht bei EuroSciVoc klassifiziert.
Schlagen Sie die Wissenschaftsbereiche vor, die Ihrer Einschätzung nach besonders relevant sind, und helfen Sie uns, unseren Klassifizierungsdienst zu verbessern.

Schlüsselbegriffe

Programm/Programme

Thema/Themen

Finanzierungsplan

HORIZON-TMA-MSCA-DN - HORIZON TMA MSCA Doctoral Networks

Alle im Rahmen dieses Finanzierungsinstruments finanzierten Projekte anzeigen

Aufforderung zur Vorschlagseinreichung

(öffnet in neuem Fenster) HORIZON-MSCA-2025-DN-01

Alle im Rahmen dieser Aufforderung zur Einreichung von Vorschlägen finanzierten Projekte anzeigen

Koordinator

TECHNISCHE UNIVERSITAET MUENCHEN
Netto-EU-Beitrag
€ 1 161 089,28
Adresse
Arcisstrasse 21
80333 Muenchen
Deutschland
Region
Bayern Oberbayern München, Kreisfreie Stadt
Aktivitätstyp
Higher or Secondary Education Establishments
Links
Gesamtkosten
Keine Daten

Beteiligte (10)

Partner (8)